Tarang Amin
J M SMUCKERAbout Tarang Amin
Independent director since 2023; age 60. Chairman and Chief Executive Officer of e.l.f. Beauty (CEO since Aug 2015; previously President/CEO Feb 2014–Jul 2015). Prior roles include CEO of Schiff Nutrition (2011–2013) and leadership positions at The Clorox Company and Procter & Gamble. Tenure on SJM Board: elected in 2023; currently serves on the Compensation and People Committee. Education not disclosed in the proxy.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| e.l.f. Beauty, Inc. | Chairman & CEO | Aug 2015–present | Took company public in 2016; leads strategy, operations, marketing, e-commerce insights valuable to SJM |
| e.l.f. Beauty, Inc. | President, CEO, Director | Feb 2014–Jul 2015 | Pre-IPO leadership and board role |
| Schiff Nutrition International | President, CEO, Director | Mar 2011–Mar 2013 | Consumer health leadership; finance/operations experience |
| The Clorox Company | Various leadership roles | Not disclosed (prior to 2011) | Consumer goods operations, marketing, supply chain expertise |
| Procter & Gamble | Various roles | Not disclosed (prior) | Brand management/consumer products experience |
External Roles
| Organization | Role | Tenure | Public/Private | Notes |
|---|---|---|---|---|
| e.l.f. Beauty, Inc. | Director (as Chairman & CEO) | 2014–present | Public | Listed under “Other Public Company Boards” |
| Pharmavite, LLC | Director | Jan 2020–present | Private | Dietary supplements board role |
| Angie’s BOOMCHICKAPOP | Director | Jun 2014–Oct 2017 | Private | Natural/organic snacks board role |
Board Governance
- Committee assignments: Member, Compensation and People Committee (“Compensation Committee”) .
- Independence: Board determined Tarang Amin is independent under NYSE/SEC rules .
- Attendance: Board met 6 times in FY2025; all directors attended at least 75% of Board and Committee meetings .
- Committee activity: Compensation Committee met 6 times in FY2025 ; scope includes executive pay philosophy, performance goals (AOI, net sales, ESG→free cash flow for FY2026), stock ownership/clawbacks, consultant oversight (Semler Brossy), and say‑on‑pay .
- Lead Independent Director: Board intends to appoint Jonathan Johnson III as Lead Independent Director upon re‑election .
- Director service limits: Executives of public companies may serve on no more than two public company boards including their own; Amin’s roles (e.l.f. + SJM) align with guideline .
Fixed Compensation
| Component (FY2025 unless noted) | Amount | Detail |
|---|---|---|
| Annual cash retainer | $100,000 | Standard for non‑employee directors |
| Committee chair fees | $0 | Compensation Committee chair fee applies to chair only; Amin is a member |
| Lead Independent Director add’l fee | $0 | Not applicable |
| Deferred Stock Units (annual grant) | $160,000 | Granted in October; DSUs vest immediately; dividends reinvested |
| Total FY2025 compensation | $260,000 | Fees Earned $100,000; Stock Awards $160,000 |
| FY2026 DSU annual grant | $170,000 | Approved increase; also $5,000 add’l retainer for serving on a second committee (not applicable if only one) |
Performance Compensation
- Performance‑based elements for directors: None disclosed; DSUs vest immediately and are not tied to performance metrics .
- Options: No stock options awarded to non‑employee directors in FY2025 .
Other Directorships & Interlocks
| Company | Type | Role | Interlock/Conflict Note |
|---|---|---|---|
| e.l.f. Beauty, Inc. | Public | Chairman & CEO; Director | Listed as other public company board; no Compensation Committee interlock reported in FY2025 |
| Pharmavite, LLC | Private | Director | No related‑party transactions disclosed at SJM |
| Angie’s BOOMCHICKAPOP | Private | Director | Prior role; no conflicts disclosed |
Compensation Committee Interlocks: Proxy states no relationships constituting interlocks under SEC rules during FY2025 .
Expertise & Qualifications
- Executive leadership across consumer goods with strengths in strategy, finance, operations, marketing, e‑commerce, people management, supply chain, and governance; board explicitly cites ability to oversee executive compensation practices .
- SJM board skills matrix emphasizes innovation/marketing, operations and supply chain, strategic transactions/M&A, people management, and corporate responsibility—areas Amin contributes to .
Equity Ownership
| Item | Amount | Notes |
|---|---|---|
| Beneficial ownership | 8,110 shares | As of June 16, 2025 |
| Deferred stock units (aggregate) | 4,244 units | As of April 30, 2025 |
| Shares held via director plans/trust | 4,285 shares | Nonemployee Director Stock/Deferred plans and equity plans |
| Options | None | Directors have no options outstanding in FY2025 |
| Ownership guideline | 5× annual cash retainer | Board policy; directors to attain within 5 years |
| Guideline compliance | Meets guideline | All non‑employee directors except Ms. Abramo met/exceeded requirement |
| Hedging/pledging | Prohibited | Insider Trading Policy bans hedging/pledging for directors |
Governance Assessment
- Strengths: Independent status; service on Compensation Committee overseeing disciplined pay practices (clawback policy, no tax gross‑ups, robust stock ownership); high shareholder support on say‑on‑pay (94% in 2024), indicating investor confidence in compensation governance; compliance with director service limits for public company executives .
- Alignment: Holds DSUs and common shares and meets 5× retainer ownership guideline; hedging/pledging prohibited, supporting alignment and risk mitigation .
- Potential risks/monitoring: Dual role as Chairman/CEO of e.l.f. Beauty poses time‑commitment considerations; however, SJM guidelines limit executives to two public boards (including their own), and policy requires advance notice of new board roles to assess conflicts/time commitments .
- Conflicts/related‑party exposure: No related‑party transactions disclosed for Amin; Compensation Committee reported no interlocks; SJM Audit Committee pre‑approves related party transactions and reviews independence annually .
Additional signals: Compensation Committee shifted short‑term incentive ESG component to free cash flow for FY2026, emphasizing cash generation and deleveraging discipline—an investor‑friendly metric oversight that Amin participates in .